← All IPOs

Manipal Health Enterprises IPO Price Band & Lot Size

MainboardListed
MANIPALHOS · · NSE

Updated · GMP, subscription and listing data refresh through the day.

Manipal Health Enterprises IPO Details

RegistrarKFin Technologies Limited
Lead managersKotak Mahindra Capital Company Limited
Offer documentDraft (DRHP)
Fresh issue₹8,000 Cr
Offer for sale₹1,275 Cr
Market cap at the offer₹77,607 Cr

Market capitalisation is the post-issue share count in the offer document’s capital structure (1,31,53,77,202 shares) multiplied by the upper end of the price band, ₹590. It is arithmetic on those two filed figures, not a valuation.

Manipal Health Enterprises Financials ₹ in crore

Revenue CAGR+29.4%2024 → 2026 · 2 yrs
Profit CAGR+31.1%2024 → 2026 · 2 yrs
Total assets CAGR+51.6%2024 → 2026 · 2 yrs
00%50005%1000010%1500015%2000020%202420252026
₹ crore202420252026
Revenue₹6,171.63₹8,242.25₹10,335.75
Expenses———
Net profit (PAT)₹533.2₹1,081.67₹916.52
PAT margin8.6%13.1%8.9%
Total assets₹10,818.83₹14,072.08₹24,864.5

Manipal Health Enterprises Shareholding before & after the IPO

Before the IPO
Pre-issue · RHP capital structure
81.43%
Promoter
After the IPO
Post-issue · as filed 04-AUG-2026
72.08%
Promoter
Promoter & promoter groupafter the IPO
Holding72.08%
Shares94,81,76,081
Through the IPO-9.35% · exiting

The founding owners and their group entities.

Breakdown as filed
Other Indian shareholders6.11%8,04,13,724
Individuals / HUF0.17%21,80,790

Post-issue pattern as filed with the NSE. Pre-issue register from the RHP capital structure, cross-checked against exchange data. Pre-issue percentages are taken from the disclosure, never estimated.

Manipal Health Enterprises IPO Lot Size & Minimum Investment by investor category

ApplicationSharesAmount at ₹590
Retail (min)1 lot25₹14,750
Retail (max)13 lots325₹1,91,750
sHNI (min)14 lots350₹2,06,500
bHNI (min)68 lots1,700₹10,03,000

One lot is 25 shares, so a single application at the ₹590 cut-off costs ₹14,750. Retail applications are capped at ₹2,00,000, which is 13 lots for this issue. Amounts are shown at the upper band because applications are made at the cut-off price.

Manipal Health Enterprises IPO Strengths & Risks as disclosed in the DRHP

▲ Strengths (8)
The company is India's largest multispecialty hospital group by bed capacity with a pan-India presence.
The company has the widest footprint in terms of presence of hospitals among private hospital chains in India.
The company operates a patient-centric ecosystem rooted in transparency, and clinical and service excellence.
The company focuses on reducing turn-around-times (TATs), adopts digital tools, and provides culturally sensitive multi-lingual support.
The company's brand, breadth of specialties, academic programs, and integrated network make it an attractive workplace for healthcare professionals.
The company provides an enabling environment for clinical advancement to doctors by offering access to advanced medical technologies and infrastructure and regular knowledge exchange.
The company routinely performs advanced interventions and complex procedures including structural heart and minimally invasive cardiac surgery.
The company has a repeatable playbook for integrating and scaling transformative acquisitions to improve access to quality healthcare.
▼ Risk factors (8)
The company's revenue from operations is derived substantially from Karnataka, and any loss of business or disruption in operations in Karnataka could have a material adverse effect.
The company primarily generates revenue by providing inpatient care at its hospitals, and any inability to maintain or improve its admissions and hospital occupancy rates could adversely affect its business.
The company derives a significant portion of its revenue from the CONGO-R specialties, and any negative changes in the demand for these specialties could adversely impact its business.
The company's reliance on third-party suppliers and subcontractors for supplies, equipment, housekeeping and security services could have a material adverse impact on its business.
The company is exposed to legal claims and regulatory actions arising from the provision of healthcare services, which could materially and adversely affect its reputation, business, financial position, and results of operations.
The company may experience delays in construction or commencement of operations at new hospitals that it builds, and may be unsuccessful in developing other facilities in the future, which may have an adverse effect on its growth, business, financial condition, results of operations, cash flows and prospects.
The company is vulnerable to failures of its information technology systems and cybersecurity risks, and any information technology failures including mishandling of medical data could interrupt its operations and adversely affect its reputation, brand, business, financial condition, results of operations, cash flows and prospects.
The company may require additional capital to support the growth of its business, and this capital might not be available on acceptable terms, if at all.

How to check Manipal Health Enterprises IPO allotment status

Allotment is decided and published by the issue’s registrar, not by the exchange and not by alphave. For Manipal Health Enterprises Limited, the registrar is KFin Technologies Limited — allotment is finalised in the days between the issue closing on 31 Jul 2026 and listing on 05 Aug 2026.

RegistrarKFin Technologies Limited
You will needPAN, application number or demat ID
Issue closes31 Jul 2026
Listing date05 Aug 2026
Issue opens
Wed, 29 Jul, 2026
Bidding 10:00 am – 5:00 pm IST
Issue closes
Fri, 31 Jul, 2026
Last day to bid · UPI mandate by 5:00 pm
Allotment finalisedTentative
Mon, 03 Aug, 2026
By KFin Technologies; check with PAN, application no. or DP ID
Refunds & UPI unblockTentative
Tue, 04 Aug, 2026
Unallotted amounts released · allotted shares credited to demat
Listing
Wed, 05 Aug, 2026
NSE · trading from 10:00 am IST

Allotment and refund dates follow SEBI’s T+3 listing timeline in trading days and are tentative until the registrar and the exchange confirm them. alphave does not hold allotment results — only the registrar can show whether an application was allotted.

The registrar publishes allotment on its own portal: KFintech. Your bank will also show the blocked amount released if shares were not allotted.

Manipal Health Enterprises IPO Price Band & Lot Size FAQs

What is the price band of Manipal Health Enterprises IPO?

The Manipal Health Enterprises Limited IPO price band is ₹590 to ₹590 per share. Applications are made at the cut-off price, which is the upper end of the band.

What is the lot size of Manipal Health Enterprises IPO?

One lot is 25 shares, so a single application at the ₹590 cut-off costs ₹14,750. Retail investors can apply for up to 13 lots within the ₹2,00,000 retail limit.

What is the minimum investment in Manipal Health Enterprises IPO?

₹14,750 — one lot of 25 shares at ₹590. Bids in the non-institutional category start above ₹2,00,000 and are made in multiples of the lot.

Is Manipal Health Enterprises IPO a mainboard or SME issue, and on which exchange?

Manipal Health Enterprises Limited is a mainboard issue listing on NSE. The lead manager is Kotak Mahindra Capital Company Limited.

What is the issue size of Manipal Health Enterprises IPO?

The issue size is ₹9,705.54 crore, of which ₹8,000 crore is a fresh issue and ₹1,275.21 crore an offer for sale by existing shareholders.

Manipal Health Enterprises IPO Registrar where allotment and refund queries go

RegistrarKFin Technologies Limited

The registrar processes the allotment and the refunds. Contact details are as printed in the offer document; the exchange and your broker cannot change an allotment.

How to Apply for the Manipal Health Enterprises IPO ASBA and UPI, as SEBI sets them

  1. Apply through your broker’s IPO window or your bank’s net banking (ASBA). The money stays in your own account and is only blocked until allotment.
  2. Choose the number of lots and bid at the cut-off price. Retail applications are capped at ₹2,00,000; above that the bid moves to the non-institutional category.
  3. If you applied through a broker, approve the UPI mandate in your payment app. The mandate must be approved by 5 pm on the day after your bid, and by 5 pm on the closing day for bids made on the last day (31 Jul 2026).
  4. One application per PAN. A second application under the same PAN is rejected, and both may be.
  5. After allotment the blocked amount is released for shares not allotted. Allotment and refund queries go to the registrar, KFin Technologies Limited, not to the exchange or the broker.

What is GMP in an IPO?

Grey Market Premium is the price at which an unlisted IPO application or share changes hands informally, before the stock is listed on the exchange. It is quoted as a rupee figure over the issue price: a premium of ₹3 on a ₹590 upper band means the grey market is dealing at ₹593.

The grey market is an over-the-counter market between private dealers. It is not operated or supervised by NSE, BSE or SEBI, no trade is settled through a clearing corporation, and no dealer is obliged to publish or honour a quote. Figures are collected by third-party reporters and different sources routinely disagree, which is why a premium can move sharply within a day or vanish entirely once bidding closes.

Grey Market Premium is an unofficial, unregulated over-the-counter datapoint reported by third parties. It is not a price, a forecast, or an indication of listing gains, and is not investment advice.